Please enable Javascript
Home
>
Episode 360: The SUNRISE Program in Bladder Cancer
Episode 360: The SUNRISE Program in Bladder Cancer
By
The Uromigos
-
Last Updated: October 16, 2024
Christopher Cutie from J&J joins the show to discuss the SUNRISE bladder program with the gemcitabine-eluting pretzel across several NMIBC and MIBC states.
Post Tags:
Uromigos-Bladder Cancer
Advertisement
Related Podcasts
Episode 381: Molecular Heterogeneity in Urothelial Carcinoma and Determinants of Clinical Benefit to PD-L1 Blockade
Uromigos-Bladder Cancer
Episode 380: The Role of SBRT in RCC
Uromigos-Kidney Cancer
Episode 378: 2025 Preview of Important GU Data
Episode 377: Prostate Cancer 2024 Highlights
Uromigos-Prostate Cancer
Episode 376: Bladder Cancer 2024 Highlights
Uromigos-Bladder Cancer
Advertisement
Advertisement